DRUGS: Test 3 Flashcards

1
Q

warfarin dosing must be ____ at the start

A

bridged, due to peak effect occurring 4-5 days after beginning treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how is warfarin metabolized

A

cyp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

warfarin AE

A

bleeding skin necrosis purple toe, pregnancy category X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the initial dose of warfarin

A

5-10 mg

if pt is elderly, malnourished, has liver disease, start with <5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how often should warfarin be monitored

A

baseline
initial: 1 week then 1-2 weeks
once stable: 6-12 weeks
out of range INR recheck within 4 weeks (usually 1-2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

general mechanisms for warfarin interactions

A
decrease vit K
displace warfarin
inhibit or induce 
increase procoag factors
additive coag response
increased bleeding risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

highly significant drug interactions

A
fluconazole
Amiodarone
Bactrim
Flagyl (FABFour)
herbals, nsiads, alc, phenytoin*, rifampin* (*PB and induce met)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

dabigatran dosing

A

DVT / PE treatment: 150 mg PO BID after 5-10 days of parenteral anticoag
prevention of recurrent DVT/PE: 150 PO BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

rivaroxaban dosing

A

DVT / PE treatment: 15 mg BIG with food for 21 days then 20 mg PO daily with food
prevention of recurrent DVT/PE: 10 mg PO daily after 6 months of initial treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

apixaban dosing

A

DVT/PE treatment: 10 mg BID for 7 days then 5 mg PO BID

prevention of recurrent DVT/PE: 2.5 mg PO BID after 6 months of initial treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

idarucizumab

A

Praxbind; moAB fragment that binds and inhibits dabigatran

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

andexanet alfa

A

modified human factor Xa molecule high affinity and specificity for factor Xa inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

UFH

A

hospitialzied with acute illness at moderate and high risk: 5000 units SC q 8-12 h
VTE treatment: 80 units/kg (5000 units) IV bolus followed by 18 units/kg/h or (1000 units) continuous infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

protamine sulfate

A

1 mg/100 units of UFH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

LMWH

A

hospitialized wih acute illness at mod or high risk of VTE: 40 mg SC daily OR 30 mg SC bid, if crcl <30: 30 mg SC daily
VTE treatment: 1 mg/kg SC q 12 h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

reversal for LMWH

A

protamine sulfate 1 mg / 1 mg of exoaparin